Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Altimmune Sector: Dual GLP-1/glucagon receptor agonists for obesity and liver disease HQ: Gaithersburg, MD Year Founded: 1997 Origin Story: Altimmune originally focused on infectious disease vaccines and biodefense, including a formative all-stock merger with PharmAthene, a US biodefense drug specialist
Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK
This prolonged action is one of the reasons these medications can have such powerful effects on appetite, blood sugar management, and weight loss
Jaypirca generated $92 million in revenue and received regulatory approval in the EU for the treatment of relapsed or refractory CLL after BTK inhibitor treatment
US$ 25.47
US$ 26.77
US$ 27.93
US$ 24.98
US$ 25.16
US$ 20.43
US$ 24.47
US$ 25.30
